Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
620.50    0.50 (0.08%)
Bid:
619.50
Ask:
620.50
Spread: 1.00 (0.161%)
Market Cap: £2.87b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Q4 Trading Statement

5 Apr 2023 07:00

RNS Number : 3901V
RS Group PLC
05 April 2023
 

5 April 2023, 7.00am

 

RS Group plc issues a trading update for the fourth quarter ended 31 March 2023 ahead of publishing full-year results on 23 May 2023

 

CONTINUED PROFITABLE GROWTH

 

DAVID EGAN, CHIEF FINANCIAL OFFICER, COMMENTED: "Effective execution and the ongoing hard work, enthusiasm and passion of our people has led to a very strong performance in 2022/23 and we anticipate full year adjusted operating profit to be slightly ahead of consensus expectations1. While revenue momentum has slowed in the fourth quarter against tough comparatives, we continue to drive profitable growth, manage our costs appropriately and invest where we can generate the greatest value."

 

SIMON PRYCE, CHIEF EXECUTIVE OFFICER, COMMENTED: "I'm excited to be joining RS at a time when we have so much potential and the strategy, people and resources to realise it. We enter 2023/24 with a strong pipeline of potential acquisition opportunities and confident in our ability to outperform even in a more difficult economic environment as we invest further to expand our solutions offer, broaden our product range, improve our digital experience and extend our technical customer service and support."

 

Like-for-like revenue growth2

Region

Q1 toJun 2022

Q2 toSep 2022

Q3 toDec 2022

Q4 toMar 20233

 

Full year to Mar 20233

EMEA

16%

14%

12%

6%

12%

Americas

24%

19%

6%

(4)%

11%

Asia Pacific

13%

6%

(8)%

(15)%

(1)%

Group

18%

15%

8%

1%

 

10%

 

Q4 trading remains solid with our industrial customers reflecting the strength of our core proposition

· Like-for-like revenue growth of 1%, despite weak electronics revenue.

· Our industrial product ranges, c.77% of Group, grew like-for-like revenue by 10%; electronic products down 14%.

· EMEA continues to outperform against tough comparatives with volume growth in our industrial ranges offsetting weaker electronics products. This reflects our more solutions-led and specialist product offer and service.

· Americas slowed in Q4 against very strong comparatives combined with a softer market, customer destocking and some rebranding disruption. We are strengthening our omni-channel and product and service solutions offer under the RS brand. Risoul, our acquisition in Mexico, is trading strongly and integration is progressing well.

· Asia Pacific continued to be impacted by a greater exposure to electronics and single-board computing, geopolitical issues in China and the hit from COVID-19 lockdowns. However, we continue to manage our costs appropriately as we invest and refocus our offer towards the industrial market and solutions.

· Our own-brand, RS PRO, grew like-for-like revenue by 16%.

· Digital like-for-like revenue increased 5%, with 1% web growth.

· Our ESG focus has been recognised with new AA and A ratings for MSCI and CDP respectively.

 

Improved gross margin and tight cost control are expected to deliver adjusted operating profit margin improvements

· Our gross margin improved, benefiting from a one-off price inflation gain and margin optimisation work.

· Tight cost control and more targeted operational investment is partially offsetting inflationary pressures.

 

Our full year profit performance is anticipated to be slightly ahead of consensus estimates1

We expect our full year revenue to be in line with consensus estimates but our adjusted operating profit to be slightly ahead reflecting gross margin benefits and strong cost control. We enter 2023/24 well positioned to face the more difficult market environment. We continue to invest in our proposition to drive further market share gains while managing our cost base appropriately as we target value creating growth and are confident of the Group's strategy and future prospects.

 

 

 

Notes:

1. Consensus for the year ended 31 March 2023 is revenue of £2,987 million within a range of £2,867 million to £3,079 million, adjusted operating profit of £382.0 million, within a range of £374.9 million to £386.2 million and adjusted profit before tax of £373.0 million within a range of £368.5 million to £376.8 million (source: RSGroup.com/investors/analyst-coverage).

2. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2021/22 is converted at 2022/23 average exchange rates for the period.  

3. Estimated figures at time of reporting.

4. We expect to see a negative impact of around £11 million on revenue from fewer trading days in 2022/23 compared to 2021/22.  

 

 

Enquiries:

David Egan

Chief Financial Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Teneo

020 7353 4200

 

 

Conference call details

There will be a conference call for analysts and investors today at 8.00am UK time. A recording of the conference will be provided shortly after the event via the investor relations page of the RS Group website: www.rsgroup.com/investors  

Please find the registration link below to join digitally. It is advisable to pre-register early to avoid any delays in joining the conference call. To ask a question, participants will need to be connected by phone.

Pre-registration link: https://webcast.openbriefing.com/rsgroup-apr23/

Participant dial in number:

United Kingdom: 020 3936 2999

All other locations: +44 20 3936 2999

Access code: 513839

Conference call timing

Date: Wednesday, 5 April 2023

Time: 8.00am UK time

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRNKQBBFBKDBQK
Date   Source Headline
3rd Jul 20238:00 amRNSCompletion of Distrelec Acquisition
30th Jun 202312:09 pmRNSNotice of Trading Update
20th Jun 202312:00 pmRNSDirector/PDMR Shareholding
15th Jun 20232:00 pmRNSDirector/PDMR Shareholding
14th Jun 20239:00 amRNSHolding(s) in Company
7th Jun 202312:00 pmRNSAnnual Financial Report
1st Jun 20239:25 amRNSTotal Voting Rights
30th May 202312:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
26th May 202310:00 amRNSDirector/PDMR Shareholding
24th May 20238:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSFinal Results
15th May 202310:00 amRNSBoard Committee Change
3rd May 20237:00 amRNSDirectorate Change
2nd May 202310:00 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSAcquisition
13th Apr 20233:43 pmRNSHolding(s) in Company
5th Apr 20237:00 amRNSQ4 Trading Statement
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20239:00 amRNSChange of Auditor
21st Mar 20239:00 amRNSBlock Listing Application
17th Mar 20234:08 pmRNSNotice of Trading Update: Change of Date
14th Mar 20231:42 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSAppointment of Simon Pryce as CEO
9th Mar 20238:00 amRNSNotice of Trading Update
1st Mar 202312:19 pmRNSTotal Voting Rights
10th Feb 20234:20 pmRNSHolding(s) in Company
1st Feb 20238:51 amRNSBlock listing Interim Review
1st Feb 20238:45 amRNSTotal Voting Rights
26th Jan 20233:00 pmRNSAdditional Listing
13th Jan 20239:00 amRNS2022 AGM Vote Outcome Update Statement
10th Jan 20237:00 amRNSTrading Statement
9th Jan 20234:30 pmRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSCompletion of Risoul Acquisition
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 20229:13 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSDirectorate Change
1st Dec 20224:54 pmRNSTotal Voting Rights
7th Nov 20227:13 amRNSDirector Declaration
3rd Nov 20227:01 amRNSHalf-year Report
3rd Nov 20227:00 amRNSCEO Leave of Absence
1st Nov 202210:54 amRNSTotal Voting Rights
6th Oct 20227:00 amRNSTrading Statement
3rd Oct 202211:00 amRNSTotal Voting Rights
28th Sep 20221:41 pmRNSNotice of Trading Update
21st Sep 202211:00 amRNSHolding(s) in Company
1st Sep 20224:02 pmRNSAppointment of Joint Corporate Broker
1st Sep 202212:05 pmRNSTotal Voting Rights
17th Aug 202211:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.